Abstract 18527: National Trends, Demographic Disparities, and Forecasted Mortality Burden of Ischemic Cardiomyopathy in the United States Through 2040
Abstract
Background: Ischemic cardiomyopathy (ICM) is a major cause of cardiovascular morbidity and mortality. Although advances in cardiovascular prevention and management have improved outcomes, whether these improvements have occurred equitably across demographic groups remains poorly characterized. We evaluated national temporal trends in age-adjusted mortality rates, demographic disparities across sex, age, and race/ethnicity, and projected mortality patterns of ICM among U.S. adults from 1999 to 2024, with forecasts through 2040. Methods: We conducted a retrospective observational study using the CDC WONDER Multiple Cause of Death database from 1999 to 2024. ICM deaths were identified using ICD-10 code I25.5 among U.S. adults aged ≥25 years. Age-adjusted mortality rates (AAMRs) per 100,000 population were calculated using the 2000 U.S. standard population. Temporal trends were analyzed using Joinpoint regression to estimate annual percent change (APC) and average annual percent change (AAPC) with 95% confidence intervals. Stratified analyses were performed by sex, age group, race/ethnicity, and place of death. ARIMA, ETS, and Prophet models were used to project mortality trends through 2040. Results: A total of 307,335 ICM deaths were identified in the United States between 1999 and 2024. The age-adjusted mortality rate (AAMR) declined from 7.13 per 100,000 population in 1999 to 3.34 in 2024, with an overall average annual percent change (AAPC) of –2.95%. Mortality rates remained consistently higher among males than females, although both groups demonstrated significant declines over time. Forecasting models projected continued reductions in mortality through 2040. Age-stratified analyses demonstrated the highest mortality burden among adults aged ≥65 years, whereas individuals aged 25-44 years had the lowest mortality rates. Although mortality declined across all racial and ethnic groups, the magnitude of improvement was unequal, with Hispanic or Latino individuals demonstrating the greatest reductions and Asian or Pacific Islander individuals showing the slowest decline. Inpatient facility death remained the most common place of death; however, home deaths increased after 2020, accompanied by declines in inpatient and nursing home deaths and increased hospice utilization. Conclusion: ICM mortality in the United States declined substantially between 1999 and 2024, with forecasting models projecting continued reductions through 2040. However, improvements were not uniform across demographic groups, with persistently higher mortality among males and older adults and variable reductions across racial and ethnic populations. These findings highlight persistent disparities despite advances in cardiovascular prevention and heart failure management.